CDXS

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 7.54 M15.33 M8.6 M38.91 M15.25 M 78.09 M Gross profit 4.81 M13.23 M6.14 M36.87 M13.18 M 69.42 M Operating expenses 28.03 M28.19 M27.55 M28.36 M23.29 M 107.39 M Selling/general/admin expenses 12.36 M12.32 M11.22 M11.19 M9.78 M 44.5 M Research & development 12.94 M13.78 M13.87 M11.72 M11.45 M 50.81 M Operating income -20.49 M-12.86 M-18.95 M10.56 M-8.04 M -29.3 M Non-Operating Income, Total -191 K-400 K-658 K-939 K-625 K -2.62 M Interest expense, net of interest capitalized 281 K291 K357 K376 K376 K 1.4 M Non-Operating Income, excl. Interest Expenses 470 K293 K277 K280 K289 K 1.14 M Unusual income/expense -942 K-984 K-1.29 M-1.59 M-1.29 M -5.16 M Pretax income -20.68 M-13.26 M-19.61 M9.62 M-8.67 M -31.92 M Equity in earnings ————— — Taxes 11 K10 K8 00018 K36 K 72 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -20.69 M-13.27 M-19.61 M9.6 M-8.7 M -31.99 M Discontinued operations ————— — Net income -20.69 M-13.27 M-19.61 M9.6 M-8.7 M -31.99 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -20.69 M-13.27 M-19.61 M9.6 M-8.7 M -31.99 M Basic earnings per share (Basic EPS) -0.25-0.16-0.220.13-0.1 -0.35 Diluted earnings per share (Diluted EPS) -0.25-0.16-0.220.13-0.1 -0.35 Average basic shares outstanding 82.41 M85.39 M90.25 M87.14 M90.77 M — Diluted shares outstanding 82.41 M85.39 M90.25 M87.14 M90.77 M — EBITDA -19.29 M-11.52 M-17.59 M11.91 M-6.76 M -23.96 M EBIT -20.49 M-12.86 M-18.95 M10.56 M-8.04 M -29.3 M Cost of revenue 2.73 M2.1 M2.46 M2.04 M2.06 M 8.67 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 1.2 M1.34 M1.36 M1.36 M1.29 M 5.34 M